Zai Lab (ZLAB) Operating Income (2018 - 2026)
Zai Lab (ZLAB) posted Operating Income of -$69.4 million for Q1 2026, little changed sequentially from -$69.4 million in Q4 2025, and down 23.22% YoY from -$90.4 million in Q1 2025.
Zai Lab (ZLAB) Operating Income (2018 - 2026) Analysis & Trends
Zai Lab has reported Operating Income for 9 years, with the latest figure at -$69.4 million in Q1 2026.
- Quarterly Operating Income fell 23.22% year-over-year to -$69.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.5 million (up 9.55% YoY) and the FY2025 annual result came in at -$229.4 million, up 18.67% from the prior year.
- Operating Income was little changed at -$69.4 million in Q1 2026 per ZLAB's latest filing, from -$69.4 million in the prior quarter.
- Over five years, Operating Income peaked at -$48.8 million in Q3 2025 and troughed at -$128.6 million in Q3 2022.
- A 5-year average of -$79.5 million and a median of -$70.3 million in 2024 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 64.88% in 2022, down 54.54% in 2022.
- Over 5 years, Operating Income stood at -$97.3 million in 2022, then declined by 27.43% to -$124.0 million in 2023, then jumped by 45.24% to -$67.9 million in 2024, then slipped by 2.23% to -$69.4 million in 2025, then increased by 0.03% to -$69.4 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$69.4 million, -$69.4 million, and -$48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | -76.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -76.49 Mn |
| Mar 31, 2026 | -69.39 Mn |
| Dec 31, 2025 | -69.41 Mn |
| Sep 30, 2025 | -48.82 Mn |
| Jun 30, 2025 | -54.90 Mn |
| Mar 31, 2025 | -56.31 Mn |
| Dec 31, 2024 | -67.89 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | -76.06 Mn |
| Mar 31, 2024 | -70.31 Mn |
| Dec 31, 2023 | -123.98 Mn |
| Sep 30, 2023 | -83.57 Mn |
| Jun 30, 2023 | -89.50 Mn |
| Mar 31, 2023 | -69.52 Mn |
| Dec 31, 2022 | -97.29 Mn |
| Sep 30, 2022 | -128.58 Mn |
| Jun 30, 2022 | -98.72 Mn |
| Mar 31, 2022 | -79.76 Mn |
| Dec 31, 2021 | -219.20 Mn |
| Sep 30, 2021 | -83.21 Mn |